Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Immunosuppression Adjustment on the Immune Response to SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients (ADIVKT)

NCT05060991 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT05060991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Immunosuppression Adjustment on the Immune Response to SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients (ADIVKT)
Lead sponsor
University of California, Davis
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 24, 2021
Completion date
December 24, 2026
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, immunosuppression, vaccine response impaired